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The prevention of ischemic injury to preserve both end-
organ function and improve neurological recovery by the
implementation of therapeutic hypothermia has been
well established in the literature. However, not only the
means by which body temperature is cooled but also the
rate by which target temperature is attained remains an
area of continued interest and research. The induction of
therapeutic hypothermia to begin the process of body
temperature lowering through the infusion of a cold solu-
tion intravenously into the body may be one variable that
influences not only rapidity of cooling but also subse-
quent clinical outcome. In a recent issue of Critical Care,
Skulec and colleagues compared the induction of thera-
peutic hypothermia by cold normal saline versus cold col-
loid solution containing hydroxyethyl starch in a porcine
animal model of cardiac arrest, assessing both the rate of
temperature change and target temperature achieved, in
addition to changes in intracranial pressure.hydroxyethyl starch both in vivo and experimentally byThe use of therapeutic hypothermia (TH) in clinical medi-
cine is no longer a rarity. A variety of methods have been
implemented in an attempt to cool patients faster [1]. In a
recent issue of Critical Care, Skulec and colleagues [2] eval-
uated the efficacy of cold normal saline as compared with a
colloid solution containing hydroxyethyl starch in the in-
duction of TH in survivors of cardiac arrest by using a por-
cine animal model of ventricular fibrillation (VF). A 20-
minute infusion of either 45 mg/mL of 1°C cold normal* Correspondence: joseph.varon@uth.tmc.edu
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© BioMed Central Ltd.2014saline or 45 mg/mL of 1°C cold colloid solution (Voluven,
6% hydroxyethyl starch 130/0.4 in normal saline; Fresenius
Kabi AG, Bad Homburg, Germany) was administered
following 5 minutes of VF and subsequent resuscitation.
Comparison of pulmonary blood temperature and cerebral
blood temperature demonstrated a statistically significant
decrease in temperature in animals given normal saline
(−2.1 ± 0.3 versus −1.6 ± 0.2°C, and −1.7 ± 0.4 versus −1.1
± 0.3°C, P <0.05, respectively). Moreover, initiation of TH
with normal saline resulted in accelerated cooling when
compared with colloid solution (−91 ± 22 versus −68
± 23°C/min, P = 0.046). The authors also performed a
mechanical substudy evaluating the specific heat capacities
of each fluid and demonstrated that normal saline resulted
in statistically more significant cooling than the studied
colloid solution (−7,155 ± 647 versus −5,733 ± 636°C/min,
P = 0.008), and this is consistent with the above clinical
in vivo findings.
These results demonstrating the differential cooling of
normal saline compared with a colloid solution containing
Skulec and colleagues are both novel academically and con-
sistent with the understanding of specific heat capacity of
solutions following the addition of solutes from thermody-
namics. Briefly, the addition of a solute to a solution results
in an increase in the number of particles that can absorb
energy and release it as heat, in turn resulting in an increase
in the temperature of the solute-solution combination rela-
tive to the solution alone when a constant amount of en-
ergy is applied [3]. As the authors demonstrated, the
thermodynamic effect of adding solute to a solution re-
sulted in statistically significant differences clinically with
respect to hypothermia induction and temperatures
attained, as well as rapidity of cooling [2].
Interestingly, the intracranial pressure (ICP) was in-
creased in animals treated with cold colloid solution
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saline solution (end infusion ICPs of 25 ± 5 and 16 ± 6 mm
Hg, respectively), which persisted for up to 90 minutes fol-
lowing infusion. The association of increased ICP with
hydroxyethyl starch was also demonstrated by Khan and
colleagues, who evaluated the combined incidence of de-
layed cerebral ischemia, hydrocephalous requiring cerebro-
spinal fluid shunting, and rebleeding in patients following
subarachnoid hemorrhage, and demonstrated a statistically
significant increase in both the combined endpoint (odds
ratio 3.1, 95% confidence interval 1.30 to 7.36, P = 0.01) and
the incidence of hydrocephalous requiring cerebrospinal
fluid shunting (odds ratio 6.1, 95% confidence interval 1.63
to 22.95, P = 0.004) [4]. The increases in both ICP and
hydrocephalous requiring cerebrospinal fluid shunting in
these two studies are most likely due to changes in cerebro-
spinal fluid absorption by the arachnoid microvilli related
to hydroxyethyl starch.
The use of colloid solutions containing hydroxyethyl
starch for volume resuscitation of critically ill patients has
been controversial, and the literature suggests both in-
creased mortality and increased need for renal replacement
therapy when compared with normal saline, and subse-
quently the US Food and Drug Administration issued a
boxed recommendation to health-care professionals not to
use hydroxyethyl starch-containing solutions in patients ad-
mitted to the intensive care unit or in patients with pre-
existing renal dysfunction [5-7]. The ICP increase seen by
Skulec and colleagues in animals treated with colloid solu-
tion may be, in part, the mechanism associated with in-
creased mortality in patients treated with hydroxyethyl
starch solutions. This study not only elucidates the de-
creased efficacy of colloid solutions containing hydroxyethyl
starch compared with normal saline in the induction of TH
in vivo but also provides insight into complications associ-
ated with hydroxyethyl starch and re-emphasizes the im-
portance of specific heat capacity of the solution with
respect to rapidity of cooling during TH induction.
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